Authors

• Helen P. Hazuda (ORCID: https://orcid.org/0000-0002-7313-4160)
• José A. Luchsinger (ORCID: https://orcid.org/0000-0002-5886-3648)
• Marcel E. Salive
• Roeland J.W. Middelbeek (ORCID: https://orcid.org/0000-0003-3862-8082)
• Christine G. Lee (ORCID: https://orcid.org/0000-0001-5637-8924)
• William C. Knowler (ORCID: https://orcid.org/0000-0002-7004-5197)
• Ashley H. Tjaden (ORCID: https://orcid.org/0000-0002-7674-5071)
• Thomas W. Storer (ORCID: https://orcid.org/0000-0002-5974-9791)
• Sharon L. Edelstein (ORCID: https://orcid.org/0000-0001-8457-4404)
• Elizabeth M. Venditti (ORCID: https://orcid.org/0000-0002-4124-6555)
• Medha N. Munshi (ORCID: https://orcid.org/0000-0001-6917-4197)
• Edward J. Boyko

Institutions

• Brigham and Women's Hospital (US)
• Joslin Diabetes Center (US)
• Milken Institute (US)
• Beth Israel Deaconess Medical Center (US)
• Harvard University (US)
• University of Puget Sound (US)
• The University of Texas at San Antonio Health Science Center (US)
• University of Pittsburgh (US)
• George Washington University (US)
• Columbia University Irving Medical Center (US)
• National Institute of Diabetes and Digestive and Kidney Diseases (US)
• Seattle Epidemiologic Information and Research Center (US)
• National Institute on Aging (US)

Publication Details

Journal

Frontiers in Public Health

Published

2024-12-18

DOI

https://doi.org/10.3389/fpubh.2024.1470035

Citations

2

Primary Topic

Diabetes, Cardiovascular Risks, and Lipoproteins

Type

article

Field-Weighted Citation Impact

0.72

Funders

• American Diabetes Association
• U.S. Department of Veterans Affairs
• Bristol-Myers Squibb
• Merck KGaA
• National Institutes of Health
• Centers for Disease Control and Prevention
• National Cancer Institute
• National Institute of Diabetes and Digestive and Kidney Diseases
• National Institute of Child Health and Human Development
• National Center for Research Resources
• Office of Research on Women's Health
• National Institute on Minority Health and Health Disparities